MOS
32
3
VRSK
32
2
OMC
66
-3
PCG
77
3
AVGO
35
-19
PRU
60
-2
NKE
31
-5
ZBH
44
2
BF.B
39
-3
DHR
68
2
WM
60
3
DUK
55
3
CMI
75
4
ICE
60
3
HSY
51
8
A
51
8
TMO
62
2
OXY
42
2
SE
54
5
BEN
57
2
MOS
32
3
VRSK
32
2
OMC
66
-3
PCG
77
3
AVGO
35
-19
PRU
60
-2
NKE
31
-5
ZBH
44
2
BF.B
39
-3
DHR
68
2
WM
60
3
DUK
55
3
CMI
75
4
ICE
60
3
HSY
51
8
A
51
8
TMO
62
2
OXY
42
2
SE
54
5
BEN
57
2
Financhill
Back

Thryv Holdings, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
41

THRY
Thryv Holdings, Inc.

Last Price:
$6.0800
Seasonality Move:
-0.69%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.68
Seasonality Move:
25.93%
Sell
41
Thryv Holdings, Inc. (THRY) is a Sell

Is Thryv Holdings, Inc. a Buy, Sell or Hold?

  • The current Thryv Holdings, Inc. [THRY] share price is $5.9700. The Score for THRY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • THRY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

THRY Stock Price Chart

What is Thryv Holdings, Inc.'s stock price today?

  • The Thryv Holdings, Inc. share price today is $5.9700
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and THRY is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

THRY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.34 Buy
Relative Strength Index (14 RSI): 42.09 Sell
Chaikin Money Flow: -756490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.6168 - 6.0168) Buy
Bollinger Bands (100): (6.9536 - 13.1736) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

THRY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.94 Buy
20-day SMA: 5.87 Buy
50-day SMA: 7.57 Sell
200-day SMA: 11.6 Sell
8-day EMA: 3.82 Buy
20-day EMA: 1.99 Buy
50-day EMA: 0.89 Buy
200-day EMA: 0.24 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

Thryv Holdings, Inc. Earnings Growth & THRY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and a decrease next year of $0.27 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Thryv Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):